Further Reading BPC-157: The Leading Combination Partner for Wound Healing Detailed overview of BPC-157, the most frequently combined peptide with GHK-Cu in skin and wound healing protocols
Why it matters: Testing both IGF-1 and IGFBP-3 together provides a more complete picture of growth hormone activity
doi:10.1186/1471-230X-12-121 Kerckhoffs AP, Akkermans LM, de Smet MB, et al
Ongoing research aims to clarify BPC-157s mechanism of reducing inflammation and promoting recovery
Vladimir Khavinson from the Sankt Petersburg University, Russia
Publication age and reagent-literature bias Much of the foundational, peer-reviewed pharmacology of Long R3 IGF-1 dates from the late 1980s and 1990s, when the analog was developed as a tool for dissecting IGFBP-versus-receptor contributions to potency and for biotechnology applications such as cell-culture media